Catalyst Wire Dossier Catalyst Wire Dossier

Tdap vaccine (combined diphtheria-tetanus-acellular pertussis vaccine)

diphtheria-tetanus-acellular pertussis vaccine · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tdap vaccine (combined diphtheria-tetanus-acellular pertussis vaccine), covering 2016-09-09 to 2016-09-09. Get the full timeline:

Most recent: Clinical Trial Update: A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine [Phase 3]

See pricing